Xeris Biopharma Holdings
Earnings Surprise
Analysts estimated XERS earnings of $0.04 per share this quarter (Q4). XERS's actual earnings were $0.06 per share.
XERS EPS surprise of 33.63%Analysts estimated XERS earnings of $-0.03 per share this quarter (Q2). XERS's actual earnings were $-0.01 per share.
XERS EPS surprise of 64.41%Analysts estimated XERS earnings of $-0.05 per share this quarter (Q1). XERS's actual earnings were $-0.06 per share.
XERS EPS surprise of -10.29%Analysts estimated XERS earnings of $-0.06 per share this quarter (Q4). XERS's actual earnings were $-0.03 per share.
XERS EPS surprise of 53.56%Analysts estimated XERS earnings of $-0.09 per share this quarter (Q3). XERS's actual earnings were $-0.11 per share.
XERS EPS surprise of -19.83%Analysts estimated XERS earnings of $-0.11 per share this quarter (Q2). XERS's actual earnings were $-0.10 per share.
XERS EPS surprise of 8.09%Analysts estimated XERS earnings of $-0.12 per share this quarter (Q1). XERS's actual earnings were $-0.14 per share.
XERS EPS surprise of -17.65%Analysts estimated XERS earnings of $-0.10 per share this quarter (Q4). XERS's actual earnings were $-0.10 per share.
XERS EPS surprise of 0.00%Analysts estimated XERS earnings of $-0.12 per share this quarter (Q3). XERS's actual earnings were $-0.09 per share.
XERS EPS surprise of -23.92%